Pulmonary Fibrosis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Pulmonary Fibrosis stocks.

Pulmonary Fibrosis Stocks Recent News

Date Stock Title
Sep 6 VCYT Insider Sale: Chief Commercial Officer-CLIA John Leite Sells Shares of Veracyte Inc (VCYT)
Sep 6 FGEN FibroGen CFO, CMO to leave company by year's end
Sep 6 BIIB Biogen’s higher Spinraza dose shows better efficacy in Phase II/III trial
Sep 6 BIIB Pandemic Darling Moderna Needs a Reality Check
Sep 5 VCYT Veracyte (VCYT) Up 9.2% Since Last Earnings Report: Can It Continue?
Sep 5 BIIB Amgen (AMGN) Up 5.8% Since Last Earnings Report: Can It Continue?
Sep 5 BIIB Biogen's Phase II/III SMA Study for Higher Spinraza Dose Meets Goals
Sep 5 VCYT The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
Sep 5 VCYT Should You Continue to Retain ABT Stock in Your Portfolio Now?
Sep 4 TRVI Trevi Therapeutics Announces Oral Presentation on Data from Ph2a CANAL Trial at the European Respiratory Society Congress 2024
Sep 4 VCYT Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors
Sep 4 BIIB Biogen Inc.'s (BIIB) Morgan Stanley's 22nd Annual Global Healthcare Conference Transcript
Sep 4 BIIB Biogen's Higher Dose Spinraza Shows To Slow Neurodegeneration Faster In Infants With Rare Neuromuscular Disorder
Sep 4 VCYT Here's Why Veracyte (VCYT) is a Strong Momentum Stock
Sep 4 BIIB High-dose Spinraza meets study goal; Top Dyne executives exit
Sep 4 BIIB Biogen announces trial win for higher Spinraza doze
Sep 4 RVPH Reviva to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Sep 4 BIIB Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA
Sep 3 FGEN FibroGen to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Sep 3 BIIB Biogen Stock Declines 20.9% Year to Date: Time to Sell?
Pulmonary Fibrosis

Pulmonary fibrosis is a condition in which the lungs become scarred over time. Symptoms include shortness of breath, a dry cough, feeling tired, weight loss, and nail clubbing. Complications may include pulmonary hypertension, respiratory failure, pneumothorax, and lung cancer.Causes include environmental pollution, certain medications, connective tissue diseases, infections (including SARS infections), interstitial lung diseases. Idiopathic pulmonary fibrosis (IPF), an interstitial lung disease of unknown cause, is most common. Diagnosis may be based on symptoms, medical imaging, lung biopsy, and lung function tests.There is no cure and there are limited treatment options available. Treatment is directed towards efforts to improve symptoms and may include oxygen therapy and pulmonary rehabilitation. Certain medications may be used to try to slow the worsening of scarring. Lung transplantation may occasionally be an option. At least 5 million people are affected globally. Life expectancy is generally less than five years.

Browse All Tags